GratXray is an innovative medical technology company specializing in breast cancer diagnosis. Our imaging systems offer accurate and painless solutions, with unprecedented tumor visibility, accuracy, and patient comfort. We have developed a unique patented method based on phase contrast enhanced X-ray imaging, which provides exceptional density contrast and tissue differentiation in low absorbing tissue, ideal for soft tissue imaging.

Our flagship product is the Grating Interferometry Breast Computed Tomography (GI-BCT) system, utilizing true 3D volumetric imaging. This groundbreaking approach enables more precise detection of breast tumors without the need for contrast agents. Unlike traditional methods, our system eliminates the need for breast compression, significantly improving patient comfort.

Additionally, our high-contrast method reduces side effects by eliminating the need for contrast agents. At GratXray, we pride ourselves on offering a one-stop solution for breast cancer imaging. Our experienced core team, comprised of co-founders, executives, and board members with extensive scientific and managerial expertise, ensures the development and delivery of cutting-edge medical devices.

For accurate, reliable, and patient-friendly breast cancer diagnosis, trust GratXray. Contact us today to learn more